Novanta (NASDAQ:NOVT - Get Free Report) posted its quarterly earnings results on Tuesday. The technology company reported $0.76 earnings per share for the quarter, beating analysts' consensus estimates of $0.71 by $0.05, Zacks reports. The company had revenue of $238.10 million for the quarter, compared to analysts' expectations of $240.29 million. Novanta had a return on equity of 15.20% and a net margin of 6.52%. Novanta's quarterly revenue was up 12.5% on a year-over-year basis. During the same period last year, the firm earned $0.63 earnings per share.
Novanta Stock Down 0.5 %
Shares of NASDAQ NOVT traded down $0.69 during mid-day trading on Friday, reaching $144.64. The company had a trading volume of 281,383 shares, compared to its average volume of 233,061. The firm has a 50 day simple moving average of $148.83 and a two-hundred day simple moving average of $164.56. Novanta has a 52-week low of $137.91 and a 52-week high of $187.12. The company has a current ratio of 2.79, a quick ratio of 1.81 and a debt-to-equity ratio of 0.61. The stock has a market cap of $5.20 billion, a P/E ratio of 86.61 and a beta of 1.28.
Wall Street Analyst Weigh In
Separately, Robert W. Baird cut their target price on Novanta from $175.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, November 6th.
Get Our Latest Analysis on NOVT
About Novanta
(
Get Free Report)
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Read More

Before you consider Novanta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.
While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.